Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik J Nel

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Lancet. Rheumatology|January 27, 2024
Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapyHendrik J Nel, Vivianne Malmström, David C Wraith, et al.
Advances in Experimental Medicine and Biology|January 9, 2010
Helminth-derived immunomodulatory moleculesPoom Adisakwattana, Sean P Saunders, Hendrik J Nel, et al.
Lancet (London, England)|June 6, 2003
Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma geneManda Rossouw, Hendrik J Nel, Graham S Cooke, et al.
The Journal of Biological Chemistry|January 20, 2011
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosisEric J Downer, Eileen Clifford, Bruno Gran, et al.
Frontiers in Immunology|January 11, 2021
Optimization of a Method to Detect Autoantigen-Specific T-Cell Responses in Type 1 DiabetesYassmin Musthaffa, Hendrik J Nel, Nishta Ramnoruth, et al.
BMC Microbiology|January 18, 2014
Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogensHendrik J Nel, Nelita du Plessis, Leanie Kleynhans, et al.
Clinical and Experimental Immunology|January 12, 2022
Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T-cell subpopulations in rheumatoid arthritis using flow cytometry-based peptide-MHC class-II tetramer stainingSwati Patel, Nishta Ramnoruth, Pascale Wehr, et al.
Clinical & Translational Immunology|August 2, 2021
Proinsulin-specific T-cell responses correlate with estimated c-peptide and predict partial remission duration in type 1 diabetesYassmin Musthaffa, Emma E Hamilton-Williams, Hendrik J Nel, et al.
Frontiers in Immunology|February 7, 2018
Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol DevelopmentDiahann T S L Jansen, Nishta Ramnoruth, Khai L Loh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2020
Altered Repertoire Diversity and Disease-Associated Clonal Expansions Revealed by T Cell Receptor Immunosequencing in Ankylosing Spondylitis PatientsAimee L Hanson, Hendrik J Nel, Linda Bradbury, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Lancet. Rheumatology|January 27, 2024
Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapyHendrik J Nel, Vivianne Malmström, David C Wraith, et al.
Advances in Experimental Medicine and Biology|January 9, 2010
Helminth-derived immunomodulatory moleculesPoom Adisakwattana, Sean P Saunders, Hendrik J Nel, et al.
Lancet (London, England)|June 6, 2003
Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma geneManda Rossouw, Hendrik J Nel, Graham S Cooke, et al.
The Journal of Biological Chemistry|January 20, 2011
Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosisEric J Downer, Eileen Clifford, Bruno Gran, et al.
Frontiers in Immunology|January 11, 2021
Optimization of a Method to Detect Autoantigen-Specific T-Cell Responses in Type 1 DiabetesYassmin Musthaffa, Hendrik J Nel, Nishta Ramnoruth, et al.
BMC Microbiology|January 18, 2014
Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogensHendrik J Nel, Nelita du Plessis, Leanie Kleynhans, et al.
Clinical and Experimental Immunology|January 12, 2022
Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T-cell subpopulations in rheumatoid arthritis using flow cytometry-based peptide-MHC class-II tetramer stainingSwati Patel, Nishta Ramnoruth, Pascale Wehr, et al.
Clinical & Translational Immunology|August 2, 2021
Proinsulin-specific T-cell responses correlate with estimated c-peptide and predict partial remission duration in type 1 diabetesYassmin Musthaffa, Emma E Hamilton-Williams, Hendrik J Nel, et al.
Frontiers in Immunology|February 7, 2018
Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol DevelopmentDiahann T S L Jansen, Nishta Ramnoruth, Khai L Loh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2020
Altered Repertoire Diversity and Disease-Associated Clonal Expansions Revealed by T Cell Receptor Immunosequencing in Ankylosing Spondylitis PatientsAimee L Hanson, Hendrik J Nel, Linda Bradbury, et al.
Pageof 3